Mizushima T - Search Results

1

Androgen Receptor Signaling Induces Cisplatin Resistance via Down-Regulating GULP1 Expression in Bladder Cancer.

Teramoto Y, Jiang G, Goto T, Mizushima T, Nagata Y, Netto GJ, Miyamoto H. Teramoto Y, et al. Among authors: mizushima t. Int J Mol Sci. 2021 Sep 17;22(18):10030. doi: 10.3390/ijms221810030. Int J Mol Sci. 2021. PMID: 34576193 Free PMC article.

2

The Role of Androgen Receptor Signaling in Ovarian Cancer.

Mizushima T, Miyamoto H. Mizushima T, et al. Cells. 2019 Feb 19;8(2):176. doi: 10.3390/cells8020176. Cells. 2019. PMID: 30791431 Free PMC article. Review.

3

Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis.

Mizushima T, Jiang G, Kawahara T, Li P, Han B, Inoue S, Ide H, Kato I, Jalalizadeh M, Miyagi E, Fukuda M, Reis LO, Miyamoto H. Mizushima T, et al. Mol Cancer Ther. 2020 Sep;19(9):1930-1942. doi: 10.1158/1535-7163.MCT-20-0050. Epub 2020 Jul 31. Mol Cancer Ther. 2020. PMID: 32737155

4

Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer.

Jiang G, Teramoto Y, Goto T, Mizushima T, Inoue S, Ide H, Nagata Y, Kashiwagi E, Baras AS, Netto GJ, Yang Z, Miyamoto H. Jiang G, et al. Among authors: mizushima t. Cancers (Basel). 2021 Feb 26;13(5):975. doi: 10.3390/cancers13050975. Cancers (Basel). 2021. PMID: 33652650 Free PMC article.

5

FOXO1 inactivation induces cisplatin resistance in bladder cancer.

Ide H, Goto T, Teramoto Y, Mizushima T, Jiang G, Nagata Y, Inoue S, Baras AS, Kashiwagi E, Miyamoto H. Ide H, et al. Among authors: mizushima t. Cancer Sci. 2020 Sep;111(9):3397-3400. doi: 10.1111/cas.14557. Epub 2020 Jul 17. Cancer Sci. 2020. PMID: 32678492 Free PMC article.

6

Androgen receptor activation: a prospective therapeutic target for bladder cancer?

Mizushima T, Tirador KA, Miyamoto H. Mizushima T, et al. Expert Opin Ther Targets. 2017 Mar;21(3):249-257. doi: 10.1080/14728222.2017.1280468. Epub 2017 Jan 19. Expert Opin Ther Targets. 2017. PMID: 28064545 Review.

7

Role of the androgen receptor in urothelial cancer.

Inoue S, Mizushima T, Miyamoto H. Inoue S, et al. Among authors: mizushima t. Mol Cell Endocrinol. 2018 Apr 15;465:73-81. doi: 10.1016/j.mce.2017.06.021. Epub 2017 Jun 23. Mol Cell Endocrinol. 2018. PMID: 28652170 Review.

8

Prostaglandin receptors induce urothelial tumourigenesis as well as bladder cancer progression and cisplatin resistance presumably via modulating PTEN expression.

Kashiwagi E, Inoue S, Mizushima T, Chen J, Ide H, Kawahara T, Reis LO, Baras AS, Netto GJ, Miyamoto H. Kashiwagi E, et al. Among authors: mizushima t. Br J Cancer. 2018 Jan;118(2):213-223. doi: 10.1038/bjc.2017.393. Epub 2017 Nov 9. Br J Cancer. 2018. PMID: 29123257 Free PMC article.

9

Expression of Phospho-ELK1 and Its Prognostic Significance in Urothelial Carcinoma of the Upper Urinary Tract.

Inoue S, Ide H, Fujita K, Mizushima T, Jiang G, Kawahara T, Yamaguchi S, Fushimi H, Nonomura N, Miyamoto H. Inoue S, et al. Among authors: mizushima t. Int J Mol Sci. 2018 Mar 8;19(3):777. doi: 10.3390/ijms19030777. Int J Mol Sci. 2018. PMID: 29518027 Free PMC article.

10

Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling.

Inoue S, Ide H, Mizushima T, Jiang G, Netto GJ, Gotoh M, Miyamoto H. Inoue S, et al. Among authors: mizushima t. Mol Cancer Ther. 2018 Jun;17(6):1303-1314. doi: 10.1158/1535-7163.MCT-17-0786. Epub 2018 Mar 28. Mol Cancer Ther. 2018. PMID: 29592878

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,005 results

Search Page